Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement

18 Jul 2018 07:00

RNS Number : 9392U
Renold PLC
18 July 2018
 

Renold plc

 

("Renold", "the Company" or "the Group")

 

AGM Statement

 

18 July 2018

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing, ahead of its Annual General Meeting to be held at 11:00am today, the following statement in respect of the first quarter of the financial year ending 31 March 2019 ('the Quarter').

 

The Quarter saw overall Group performance in line with expectations. Improving order intake in the second half of the previous year was converted into growth in underlying1 revenue in the Quarter of 3.7%, compared to the first quarter of the prior year. Higher sales are being delivered in both divisions, with underlying revenue ahead by 3.1% for Chain and 4.9% for Torque Transmission.

 

The trend of orders growing at a faster rate than revenue has continued into the early part of the new financial year, with order intake in the Quarter 9.2% ahead of revenue in the same period (book to bill ratio). Underlying order intake was 12% higher than in the first quarter of the prior year (excluding the major multi-year project win by UK Couplings in June 2017).

 

Progress continues to be made in building our new Chinese chain factory, with construction nearing completion. The phased transfer of manufacturing operations will be undertaken over the coming months, with full operation from the new facility scheduled for the end of the financial year.

 

The Group remains on track to deliver a result for the full year in line with the Board's expectations.

 

Robert Purcell, Chief Executive of Renold, said:

"Strong order intake in the latter part of the prior year supported growing revenues in the Quarter across most of our geographic regions, with the Americas particularly strong in both the Chain and Torque Transmission divisions.

 

"Continued revenue growth provides the platform for margin improvement supported by continued progress in delivering against our strategic plan."

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by re-translating the prior year comparative figures to the current year exchange rate.

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Ian Scapens, Group Finance Director

 

 

 

Arden Partners

020 7614 5917

Chris Hardie

 

Ben Cryer

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Helen Tarbet

Rosie Driscoll

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSFWFIWFASEDW
Date   Source Headline
18th Jun 202010:37 amRNSDirector/PDMR Shareholding
18th Jun 20208:00 amRNSBlock listing Interim Review
17th Jun 202011:12 amRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSFinal Results
28th May 20203:41 pmRNSHolding(s) in Company
27th May 20207:00 amRNSPreference Stock Dividend
12th May 20207:00 amRNSDirectorate Change
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20202:21 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTrading Update and Impact of Coronavirus
18th Dec 20197:00 amRNSBlock listing Interim Review
27th Nov 20197:00 amRNSPreference Stock Dividend
22nd Nov 20193:00 pmRNSGrant of Award - Performance Share Plan
18th Nov 20199:27 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSDirectorate Changes
13th Nov 20197:00 amRNSHalf-year Report
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
14th Oct 20197:00 amRNSTrading Update
20th Sep 20194:58 pmRNSResult of AGM (replacement)
20th Sep 20192:07 pmRNSResult of AGM
27th Aug 20194:05 pmRNSRevised 2019 Annual Report and Accounts
27th Aug 20197:00 amRNSCompletion of investigation
21st Aug 201912:04 pmRNSHolding(s) in Company
17th Jul 20191:23 pmRNSAdjournment of Annual General Meeting 2019
12th Jul 20199:30 amRNSHolding(s) in Company
10th Jul 20199:10 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSPostponement of Annual General Meeting
19th Jun 20197:00 amRNSBlock Listing Application
18th Jun 20198:00 amRNSAnnual Report and Accounts
17th Jun 201912:07 pmRNSSecond Price Monitoring Extn
17th Jun 201912:02 pmRNSPrice Monitoring Extension
7th Jun 20198:05 amRNSAdmission to trading on AIM
4th Jun 20195:30 pmRNSRenold
3rd Jun 201911:30 amRNSSchedule One update - Renold plc
3rd Jun 20197:00 amRNSTimetable update
28th May 20197:00 amRNSFinal Results
8th May 20191:54 pmRNSResult of General Meeting
8th May 201911:30 amRNSSchedule 1 - Renold Plc
11th Apr 20192:42 pmRNSPosting of shareholder circular
11th Apr 20197:01 amRNSTrading Update
11th Apr 20197:00 amRNSProposed move from Official List to AIM
1st Apr 20197:00 amRNSExtension of Banking Facilities
4th Feb 20198:00 amRNSBlock listing Interim Review
28th Jan 201912:53 pmRNSHolding(s) in Company
16th Nov 20182:39 pmRNSHolding(s) in Company
16th Nov 20182:38 pmRNSHolding(s) in Company
16th Nov 20182:35 pmRNSHolding(s) in Company
15th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 20187:01 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.